PT-141
Bremelanotide — Melanocortin Receptor Agonist [Ac-Nle-c(Asp-His-D-Phe-Arg-Trp-Lys)-OH]
PT-141 (Bremelanotide; Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH) is a synthetic cyclic heptapeptide differing from Melanotan II solely by a free C-terminal carboxylic acid rather than a primary amide. It acts as a non-selective agonist at MC1R, MC3R, and MC4R with documented activity in central hypothalamic and limbic melanocortin pathways. Research has characterised its receptor binding kinetics, ligand selectivity across MC1R–MC5R subtypes, cAMP signalling dynamics, and neuropeptide-driven transcriptional responses in neuronal and transfected cell model systems.
| PROPERTIES | |
|---|---|
| Molecular Formula | C50H68N14O10 |
| Molecular Weight (g/mol) | 1025.2 |
| Monoisotopic Mass (Da) | 1024.5243 |
| Topological Polar Surface Area (Ų) | 379 |
| Complexity | 1950 |
| XLogP (octanol-water partition) | 0.7 |
| Heavy Atom Count | 74 |
| H-Bond Donor Count | 13 |
| H-Bond Acceptor Count | 12 |
| Rotatable Bond Count | 17 |
| InChIKey | FFHBJDQSGDNCIV-MFVUMRCOSA-N |
| PubChem CID | 9941379 |
All values above are taken from PubChem CID 9941379 and can be checked against that record.
2D Structure
| CHEMICAL IDENTIFIERS | |
|---|---|
| CAS Number | 189691-06-3 |
| PubChem CID | 9941379 |
| IUPAC Name | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid |
| InChIKey | FFHBJDQSGDNCIV-MFVUMRCOSA-N |
| InChI | InChI=1S/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41-/m0/s1 |
| SMILES | CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C |
Identifiers retrieved from PubChem CID 9941379.
HPLC purity report Sample lot
PT-141
- Lot
- P260711-LR056212
- SKU
- GD-PT141
Integration table as reported
| # | Ret. time | Height | Area | Area % | |
|---|---|---|---|---|---|
| 1 | 8.393 | 6251 | 68589 | 0.6644 | |
| 2 | 8.838 | 807695 | 10209095 | 98.89 | |
| 3 | 9.196 | 4711 | 45978 | 0.4454 | |
Retention time in minutes. Height and area are the report’s own values and units. Method wording is normalised for units and spelling; every value is as reported.
Method as reported
| Column | Sinochrom ODS-BP-5 C18, 4.6 × 250 mm, 5 µm |
|---|---|
| Mobile phase A | 0.1% trifluoroacetic acid in acetonitrile |
| Mobile phase B | 0.1% trifluoroacetic acid in water |
| Flow rate | 1.0 mL/min |
| Detection | 220 nm |
| Injection volume | 20 µL |
| Time | A | B |
|---|---|---|
| 0.0min | 30% | 70% |
| 25.0min | 55% | 45% |
| 25.1min | 100% | 0% |
| 30.0min | Stop | |
Identity verified against PubChem, not a measurement of this lot
- CAS number
- 189691-06-3
- Molecular formula
- C50H68N14O10
- Molecular weight
- 1025.2 g/mol
- Monoisotopic mass
- 1024.5243 Da
- InChIKey
- FFHBJDQSGDNCIV-MFVUMRCOSA-N
- PubChem CID
- 9941379
Corrections and queries 1 corrected
| Field | On the supplier document | Here | Why |
|---|---|---|---|
| CAS number | 32780-32-8 | 189691-06-3 | 32780-32-8 belongs to validamine, a different compound. 189691-06-3 is bremelanotide and matches the sequence printed on the report, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. |
A measured result is never rewritten. Where a reported figure does not stand up, it is shown as printed and marked as queried.
Sample lot. This is the report supplied with the sample of this compound. A production lot ships with its own report, published here in the same form and indexed by its own lot number.
Every analytical figure above is transcribed from the supplier’s report for lot P260711-LR056212. Identity is the PubChem record, which can be checked independently. Purity is the main peak’s share of integrated peak area at the detection wavelength, so it measures related impurities. Water, salts and counter-ions are not part of it. These are the supplier’s release documents, not independent third-party tests.
This product is sold exclusively for in vitro and laboratory research use. It has not been evaluated by the FDA. Not approved for diagnostic, therapeutic, or veterinary use.
Thymosin alpha-1
Retatrutide
KPV
Tirzepatide